TABLE 6.
Indicators of presence of buprenorphine and methadone in selected data sets: 2007 and 2008
| NFLIS–% of all cases examined: 2008 | N-SSATS clients/100,000: 2007 | ARCOS dosage units/100,000: 2008 | |
|---|---|---|---|
| Buprenorphine | Buprenorphine | Buprenorphine | |
| Midwest | 0.6 | 0.7 | 3553.0 |
| Northeast | 3.6 | 1.3 | 6057.0 |
| South | 1.6 | 1.2 | 5597.0 |
| West | 0.5 | 1.1 | 5312.0 |
| Methadone | Methadone | Methadone | |
| Midwest | 1.9 | 59.4 | 3575.0 |
| Northeast | 2.7 | 170.4 | 7061.0 |
| South | 3.8 | 80.5 | 5337.0 |
| West | 2.0 | 80.3 | 5573.0 |